Simris Group
0,078 SEK -4,65%1 investor følger denne virksomhed
Simris Group is a biotechnology company. The company is focused on research and development as well as the production of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals, and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. The first product is omega-3 supplements that are sold under their own brand. Simris Group was founded in 2011 and is headquartered in Hammenhög.
Læs mereOmsætning
4,35 mio.
EBIT %
-842,3 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
SIMRIS B
Daglig lav / høj pris
0,075 / 0,084
SEK
Markedsværdi
27,15 mio. SEK
Aktieomsætning
18,25 t SEK
Volumen
228 t
Finanskalender
Delårsrapport
13.11.2024
Årsrapport
26.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
SIX SIS AG, W8IMY | 19,1 % | 19,1 % |
Goldman Sachs & Co. LLC, W9 | 7,1 % | 7,1 % |
Avanza Pension | 4,7 % | 4,7 % |
Deutsche Bank AG, W8IMY | 3,6 % | 3,6 % |
Dan Enke | 3,2 % | 3,2 % |
Goldman Sachs International, W8IMY | 3,2 % | 3,2 % |
CBNY-National Financial Services LL | 2,9 % | 2,9 % |
JP Morgan Chase Bank NA, W9 | 2,6 % | 2,6 % |
Bengt Johansson | 2,2 % | 2,2 % |
Nordnet Pensionsförsäkring AB | 1,7 % | 1,7 % |
ViserAlle indholdstyper
Simris Group chairman and major owner Steven Schapera has passed away after complications after surgery
Simris Biologics awarded funding for a research collaboration with Berlin's University of Applied Science to explore the ability of natural compounds from Cyanobacteria to delay aging
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools